Module

Using Recently Approved Antiretrovirals in the Management of a Highly Treatment–Experienced HIV-Infected Woman

Source: Rethinking the Role of NNRTIs: Clinical Strategies for Optimizing Outcomes With Next-Generation Agents

Using Recently Approved Antiretrovirals in the Management of a Highly Treatment–Experienced HIV-Infected Woman


Faculty:

W. David Hardy, MD
  • W. David Hardy, MD

CME CREDIT INFORMATION

Release Date: 03/18/08

Expiration Date: 03/17/09


Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.7 Nursing CE credits

Status: Please log in to view status

Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the use of etravirine in combination with other new and existing antiretrovirals in triple class–experienced patients
  • Summarize the clinical data on the efficacy of raltegravir among treatment-experienced individuals
  • Define treatment options for HIV-infected patients with multidrug-resistant virus
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.